Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

AMA and ROFIM launch surgical teleassistance platform

EditorNatashya Angelica
Published 01/02/2024, 07:38
© Reuters.

RENNES, France - AMA CORPORATION PLC (Euronext Growth Paris:ALAMA) in collaboration with telemedicine software developer ROFIM, has announced the launch of a new global surgical remote assistance solution. The technology is designed to support the full spectrum of surgical care including pre-operative, peri-operative, and post-operative phases.

This web-based solution facilitates tele-expertise and remote expert assistance, allowing medical centers to obtain specialist opinions by sharing patient medical files and preoperative images. During surgeries, the system enables surgeons to share their view in real-time with remote experts who can assist with various functionalities such as video pointing, annotations, and live document sharing.

Dr. Daniel Pietrasz, a surgeon at the Paul-Brousse AP-HP hospital, highlighted the benefits of this secure, encrypted solution that does not store data. It allows for expertise transfer, maintains activity for complex cases, and offers patients access to surgical expertise for better management of their treatment.

The platform also serves as an intra-hospital tool to aid junior surgeons. It has been implemented in several healthcare establishments, including the BOPA innovation chair, and is part of the France 2030 plan, which aims to foster innovation in healthcare.

AMA, known for its secure telemedicine applications and the XpertEye suite, serves various healthcare facilities and MedTech companies. ROFIM, since 2018, has provided telemedicine software to thousands of doctors and healthcare establishments, offering a comprehensive platform for teleconsultations and secure file transfers.

The collaboration between AMA and ROFIM demonstrates the growing integration of digital tools in healthcare, promoting new forms of cooperation between medical centers. This press release statement serves as the source of information for this article.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

As AMA Corporation PLC ventures into new territories with its telemedicine solutions, the financial health of the company remains a critical factor for investors to consider. According to recent data from InvestingPro, AMA Corporation holds a market capitalization of just $5.34 million USD, reflecting its status as a small-cap company. The firm's Price / Book multiple as of the last twelve months ending Q2 2023 stands at 0.52, indicating that the stock may be trading at a low valuation relative to the company's book value. This could be of interest to value investors looking for potential bargains.

On the operational front, AMA Corporation has faced challenges, with a gross profit margin of -12.68% and an operating income margin of -249.66% during the same period. These figures suggest that the company is currently not generating profit from its operations, and has been quickly burning through cash. Revenue has also seen a decline of -19.7% over the last twelve months as of Q2 2023. Despite these financial headwinds, it's notable that the stock has experienced a strong return over the last three months, with a price total return of 120.0%.

For those considering an investment in AMA Corporation, it may be worthwhile to explore the additional 15 InvestingPro Tips available with an InvestingPro+ subscription, which is now on a special New Year sale with a discount of up to 50%. Use coupon code SFY24 to get an additional 10% off a 2-year subscription, or SFY241 to get an additional 10% off a 1-year subscription. These tips provide deeper insights into the company's financial health and market position, which could be invaluable in making a well-informed investment decision.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.